Abstract
Purpose
Tumorigenesis of medulloblastoma is believed to be associated with granule cell progenitor neurogenesis of the cerebellum. Nevertheless, congenital medulloblastomas are rarely found. Here, we report a case of congenital medulloblastoma that showed spontaneous albeit transient regression.
Methods
A one-month-old baby presented with abnormal antenatal and postnatal imaging findings. Upon ultrasonography at 26 weeks of gestational age, Dandy-Walker malformation with vermian hypoplasia and cystic change was suspected. Brain MRI at 1 week after birth revealed gadolinium-enhancing lesions in the cerebellum with apparent infiltrative features along the cerebellar folia accompanied by three independent cysts in the upper and inferolateral sides of the lesion. Serial MRIs taken up to 5 months of age showed a decrease in the size and extent of enhancing solid portions. The baby did not show any abnormal signs or developmental delay. MRI at the age of 7 months showed enlargement of the lesion, and surgery was performed.
Results
The lesion was diagnosed as medulloblastoma with histologically extensive nodularity (MBEN), genetically SHH-activated and TP53-wildtype.
Conclusion
This case provides an unusual chance of observing an early phase of medulloblastoma development and raises a suspicion that medulloblastoma may initiate itself very early in cerebellar organogenesis and progress later at a certain time of postnatal development.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Tumorigenesis of medulloblastoma is believed to be associated with granule cell progenitor neurogenesis of the cerebellum [1]. Non-coding RNAs including Sonic Hedgehog (SHH) pathways are known to have a crucial role, which are also important for the development of the cerebellum [2]. Nevertheless, medulloblastomas are rarely found as a congenital brain tumor compared with other brain tumors, such as atypical teratoid/rhabdoid tumor (AT/RT). Moreover, congenital medulloblastomas behave unexpectedly.
Case report
A 1-month-old baby presented with abnormal antenatal and postnatal imaging findings. He was born at a gestational age (GA) of 38 weeks with a birth weight of 2950 g. He was the first baby to the parents, both of whom had no specific disease history. Upon ultrasonography at 26 weeks of GA for routine screening, cerebellar dysplasia with hyperechoic cortex was observed (Fig. 1). The hyperechoic portion grew into a large complex mass containing cysts at 33 weeks. Nevertheless, the gestational period was uneventful, and the baby was born spontaneously at full term. Brain MRI at 1 week after birth revealed gadolinium-enhancing lesions in the cerebellum with apparent infiltrative features along the cerebellar folia accompanied by three independent cysts in the upper and inferolateral sides of the lesion (Fig. 2). A malignant brain tumor, such as AT/RT, was the initial diagnosis based on the MRI findings. However, surgery was postponed until the baby gained more weight because the baby was too small and there were no urgent signs of hydrocephalus, increased intracranial pressure (IICP), or other neurological deficits.
Surprisingly, at the age of 3 months, MRI showed a decrease in the size and extent of enhancing solid portions, with stippled enhancement through the cerebellar surface (Fig. 2). Abdominal ultrasonography and urine metabolite analysis were performed, but no abnormal findings were obtained, so metastatic neuroblastoma was excluded from diagnosis. Gorlin syndrome was also excluded since none of the diagnostic criteria was met, such as basal cell carcinoma or intracranial calcification [3]. The baby showed no signs of systemic inflammation. Hence, a primary brain tumor could not be ruled out. Upon observing the decrease in the extent of the disease and the stability of the patient’s condition, surgery was postponed, and he was followed with serial brain MRIs. The baby developed normally, with a head circumference within the normal range and no neurological deficits.
Brain MRI at the age of 5 months revealed a slight decrease in lesion infiltration compared with the last MRI. Surgery was again postponed for a short time, until MRI at the age of 7 months showed clear enlargement of both enhancing solid and cystic portions (Fig. 2). Surgery was performed. Nodular masses were connected by cysts occupying the vermis and cerebellar hemispheres. Thin tumor spreading along the cerebellar folia was noted. The lesion was well demarcated, gray colored, and hypervascular. The mass and cyst walls were almost completely removed.
Histological findings of the tumor are shown in Fig. 3. A comprehensive gene panel of 72 genomic alterations showed no alterations except a CDH1 missense mutation (p.Met272Val, c.814A>G) (Table 1). The final diagnosis was medulloblastoma with histologically extensive nodularity (MBEN), genetically SHH activated, and TP53 wildtype.
The baby, currently at 1 year after the operation, has finished the third cycle of chemotherapy (carboplatin, etoposide, ifosfamide, vincristine, and mesna). No sign of recurrence is seen on the MRI. Although he has a mild motor development delay, he is catching up with the developmental stage appropriate for his age.
Discussion
Congenital brain tumors are rare and account for less than 2% of pediatric brain tumors [4]. Despite a few previous reports on congenital medulloblastoma, to the best of our knowledge, only two have reported true (i.e., found antenatally) congenital medulloblastomas [5, 6]. MRI in both cases revealed multiple cystic components, as in our case. Both patients presented with obstructive hydrocephalus and IICP signs, and the tumors grew steadily and required surgery [5, 6]. One tumor was diagnosed as a desmoplastic/nodular subtype, and the other report did not provide subtype information. The patient in the desmoplastic/nodular subtype case survived to the time of the report without recurrence, but the patient in the other case expired of the disease [5, 6].
Our case is intriguing in some aspects. First, the tumor showed transient but spontaneous regression after birth. Spontaneous tumor regression has been reported in many brain tumors, most of which are low-grade tumors, such as pilocytic astrocytoma [7]. However, the spontaneous regression of high-grade brain tumors is exceedingly rare, and little is known about medulloblastoma. While the mechanism has to be elucidated, we could make inferences from an experimental animal model. Smoothened (Smo) A2 transgenic mice, which highlights a key transducer of the SHH pathway, was characterized, and cerebellar developmental dysplasia but normal neurological function of the mice were reported [8]. Interestingly, progenitor cells of the developing cerebellum had neoplastic characteristics morphologically and functionally and had shown apparent regression of the hypercellularity in SmoA2 mice [8].
Second, the baby did not show abnormal signs or developmental delay. The tumor behaved as if it was supposed to be there since the first detection. The “true” congenital medulloblastomas in the literature were all detected between late 20 and early 30 weeks of GA. This is when the cerebellum significantly expands during organogenesis [9]. Therefore, in our case, the tumor may “literally” be an embryonic tumor that developed together with the cerebellum. Aberrant SHH signaling during development has been presented as the evidence of prenatal origin of medulloblastoma [9].
Third, the tumor showed CDH 1 mutation which has been rarely reported in medulloblastoma. A genomic landscape of 79 medulloblastomas revealed two missense mutations in CDH1 [10]. CDH1 gene encodes epithelial cadherin or E-cadherin, which is an important molecule in cell adhesion and stability of epithelial tissue [11]. Comprehensive studies are needed to explore the association between CDH 1 and medulloblastoma.
We report a case of congenital medulloblastoma that showed spontaneous albeit transient regression. This case provides an unusual chance of observing an early phase of medulloblastoma development and raises a suspicion that medulloblastoma may initiate itself early in cerebellar organogenesis and progress later at a time of postnatal development.
References
Espinosa JS, Luo L (2008) Timing neurogenesis and differentiation: insights from quantitative clonal analyses of cerebellar granule cells. J Neurosci 28:2301–2312
Hatten ME, Roussel MF (2011) Development and cancer of the cerebellum. Trends Neurosci 34:134–142
Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, Bale AE, Bale SJ (1997) Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69:299–308
Nikas I, Themistocleous M, Vraka I, Pitsoulakis G (2016) Congenital brain tumors. J Pediatr Neuroradiol 5:054–069
Komatsu F, Tsugu H, Nonaka M, Tsutsumi M, Yanai F, Yukitake K, Utsunomiya H, Fukushima T (2008) Congenital medulloblastoma with atypical MRI appearance. Pediatr Neurosurg 44:165–168
Korostyshevskaya AM, Savelov AA, Papusha LI, Druy AE, Yarnykh VL (2018) Congenital medulloblastoma: fetal and postnatal longitudinal observation with quantitative MRI. Clin Imaging 52:172–176
Schmandt SM, Packer RJ, Vezina LG, Jane J (2000) Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 32:132–136
Dey J, Ditzler S, Knoblaugh SE, Hatton BA, Schelter JM, Cleary MA, Mecham B, Rorke-Adams LB, Olson JM (2012) A distinct smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model. Mol Cell Biol 32:4104–4115
Marshall GM, Carter DR, Cheung BB, Liu T, Mateos MK, Meyerowitz JG, Weiss WA (2014) The prenatal origins of cancer. Nat Rev Cancer 14:277–289
Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, Phoenix TN, Hedlund E, Wei L, Zhu X, Chalhoub N, Baker SJ, Huether R, Kriwacki R, Curley N, Thiruvenkatam R, Wang J, Wu G, Rusch M, Hong X, Becksfort J, Gupta P, Ma J, Easton J, Vadodaria B, Onar-Thomas A, Lin T, Li S, Pounds S, Paugh S, Zhao D, Kawauchi D, Roussel MF, Finkelstein D, Ellison DW, Lau CC, Bouffet E, Hassall T, Gururangan S, Cohn R, Fulton RS, Fulton LL, Dooling DJ, Ochoa K, Gajjar A, Mardis ER, Wilson RK, Downing JR, Zhang J, Gilbertson RJ (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43–48
Berx G, Becker KF, Hofler H, van Roy F (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226–237
Funding
This study was supported by a grant from the National Research Foundation (NRF) of Korea (No. 2018R1D1A1A02086005) to Phi JH and a grant from the Seoul National University Hospital (No. 0320180440) to Phi JH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yang, J., Kim, SK., Wang, KC. et al. A boy with a congenital cerebellar mass. Childs Nerv Syst 37, 983–987 (2021). https://doi.org/10.1007/s00381-020-04767-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04767-4